Anticipated and Perceived Benefits Following Hepatitis C Treatment
- Conditions
- Hepatitis CHepatitis C, Chronic
- Registration Number
- NCT03000023
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Brief Summary
The study is both qualitative and quantitative, gathering patient's perceptions of HCV treatment benefits before and after HCV treatment by administering surveys and conducting in-depth qualitative patient interviews. The study seeks to understand all anticipated and actual benefits patients perceive before and after viral eradication.
- Detailed Description
This study employs a mixed methods (qualitative and quantitative) pre-post study design utilizing in-depth qualitative interviews and patient reported outcome surveys. Pre-treatment surveys and interviews will be conducted before HCV therapy commences to understand all potential psychological, social, physical and medical consequences perceived to be related to HCV and the patients' anticipation (hope for) of improvements in these factors after viral eradication. Post-treatment surveys and interviews will occur 4 to 8 months after treatment ends to examine long-term treatment benefits, i.e., changes in HCV-related factors, such as symptoms, functioning, and health status.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Age 21 or older
- English-speaking
- Any genotype
- Any treatment duration (e.g. 8, 12, or 24 weeks)
- Has been written a prescription for a sofosbuvir (SOF)-containing regimen.
- Currently listed for liver transplant; post-liver transplant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analyze changes in patient perceptions through qualitative interviews before and after HCV treatment. 1 Year To conduct a pre-post qualitative analysis that will evaluate changes in a broad range of patients' perceptions of psychological, social, and physical effects associated with HCV and viral cure collected through qualitative interviews.
Evaluate pre-post survey change in patient reported HCV symptoms and other factors. 1 Year To conduct a pre-post survey evaluation of change in patient-reported HCV symptoms, functioning, and health perceptions associated with HCV and viral cure.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of North Carolina
🇺🇸Chapel Hill, North Carolina, United States